
Asparaginase erwinia chrysanthemi (recombinant)-rywn) (Rylaze; Jazz Pharmaceuticals) provides a new alternative for a therapy in long-standing global shortage.
Asparaginase erwinia chrysanthemi (recombinant)-rywn) (Rylaze; Jazz Pharmaceuticals) provides a new alternative for a therapy in long-standing global shortage.
Disaster preparedness—a necessity for specialty pharmacies and their service providers, suppliers, and patients—goes well beyond stockpiling water and food supplies.
Health care industry trends affecting specialty pharmacy were the focus of a presentation at Asembia’s 2018 Specialty Pharmacy Summit.
Creating and delivering an optimal patient experience was at the forefront of an educational presentation Tuesday, May 8 at Asembia’s 2018 Specialty Pharmacy Summit in Las Vegas, Nevada.
The huge financial and human costs make the opioid epidemic a timely and significant topic of discussion among pharmacists.
A Connecticut health system was able to transform the way it manages oral oncology services to improve patient outcomes and experiences.
Published: July 20th 2018 | Updated:
Published: June 25th 2018 | Updated:
Published: June 26th 2018 | Updated:
Published: June 25th 2018 | Updated:
Published: June 25th 2018 | Updated:
Published: June 25th 2018 | Updated: